The long-term influence of orlistat on dietary intake in obese subjects with components of metabolic syndrome

Journal of Human Nutrition and Dietetics

Volumn 22, Issue 1, 2009, Pages 55-63

  Svendsen, Mette ^a   Helgeland, M ^a   Tonstad, S ^a  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

Anti obesity drug; Dietary adherence; Energy expenditure; Food choice; Weight maintenance

Indexed keywords

CARBOHYDRATE; PLACEBO; TETRAHYDROLIPSTATIN;

ABDOMINAL PAIN; ABNORMAL FECES; ADULT; ARTICLE; BODY MASS; CALORIC INTAKE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEFECATION; DEFECATION HABIT; DIETARY INTAKE; DISEASE ASSOCIATION; FAT INTAKE; FATTY EVACUATION; FECAL URGENCY; FEEDING BEHAVIOR; FEMALE; FLATULENCE; HEALTH PROGRAM; HUMAN; LIFESTYLE MODIFICATION; LONG TERM CARE; MALE; METABOLIC SYNDROME X; MULTICENTER STUDY; NUTRITIONAL ASSESSMENT; OBESITY; OILY SPOTTING; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SCANDINAVIA; SIDE EFFECT; VOMITING; WEIGHT REDUCTION;

EID: 58549089324     PISSN: 09523871     EISSN: 1365277X     Source Type: Journal    
DOI: 10.1111/j.1365-277X.2008.00920.x     Document Type: Article

References (31)

1. Andersen, L.F., Solvoll, K., Johansson, L.R., Salminen, I., Aro, A. & Drevon, C.A. (1999) Evaluation of a food frequency questionnaire with weighed records, fatty acids, and alpha-tocopherol in adipose tissue and serum. Am. J. Epidemiol. 150, 75-87.
2. Astrup, A. & Rössner, S. (2000) Lessons from obesity management programmes: Greater initial weight loss improves long-term maintenance. Obes. Rev. 1, 17-19.
3. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (2001) Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 285, 2486-2497.
4. Frankenfield, D., Roth-Yousey, L. & Compher, C., for the Evidence Analysis Working Group. (2005) Comparison of predictive equations for resting metabolic rate in healthy nonobese and obese adults: A systematic review. J. Am. Diet. Assoc. 105, 775-789.
5. Franson, K. & Rössner, S. (2000) Fat intake and food choices during weight reduction with diet, behavioural modification and a lipase inhibitor. J. Intern. Med. 247, 607-614.
6. Golay, A., Laurent-Jaccard, A., Habicht, F., Gashoud, J.P., Chabloz, M., Kammer, A. & Schutz, Y. (2005) Effect of orlistat in obese subjects with binge eating disorders. Obes. Res. 13, 1701-1708.
7. Goris, A.H.C., Westerterp-Platenga, M.S. & Westerterp, K. (2000) Undereating and underrecording of habitual food intake in obese men: selective under-reporting of fat intake. Am. J. Clin. Nutr. 71, 130-134.
8. Grundy, S.M., Cleeman, J.I., Daniels, S.R., Donato, K.A., Eckel, R.H., Franklin, B.A., Gordon, D.J., Krauss, R.M., Savage, P.J., Smith, S.C. Jr, Spertus, J.A. & Costa, F. (2005) Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation 112, 2735-2752.
9. Guerciolini, R. (1997) Mode of action of orlistat. Int. J. Obes. Relat. Metab. Disord. 21, 12S-23S.
10. Hill, R.J. & Davies, P.S.W. (2001) The validity of self-reported energy intake as determined using the doubly labelled water technique. Br. J. Nutr. 85, 415-430.
11. Hill, J.O., Hauptman, J., Anderson, J.W., Fujioka, K., O'Neil, P., Smith, D.K., Zavoral, J.H. & Aronne, L.J. (1999) Orlistat, a lipase inhibitor, for weight maintenance after conventional dieting: A 1-y study. Am. J. Clin. Nutr. 69, 1108-1116.
12. Hustvedt, B.-E., Christophersen, A., Johnsen, L.R., Tomten, H., McNeill, G., Haggarty, P. & Løvø, A. (2004) Description and validation of the Actireg ®: A novel instrument to measure physical activity and energy expenditure. Br. J. Nutr. 92, 1001-1008.
13. Hustvedt, B.-E., Svendsen, M., Løvø, A., Ellegård, L., Hallén, J. & Tonstad, S. (2008) Validation of ActiReg to measure physical activity and energy expenditure against doubly labelled water in obese persons. Br. J. Nutr. 100, 219-226.
14. Krempf, M., Louvet, J.-P., Allanic, H., Miloradovich, T., Joubert, J.-M. & Attali, J.-R. (2003) Weight reduction and long-term maintenance after 18months treatment with orlistat for obesity. Int. J. Obes. 27, 591-597.
15. Lindroos, A.K., Lissner, L. & Sjöström, L. (1993) Validity and reproducibility of a self-administered dietary questionnaire in obese and non-obese subjects. Eur. J. Clin. Nutr. 47, 461-481.
16. Livingstone, M.B.E. & Black, A.E. (2003) Markers of the validity of reported energy intake. J. Nutr. 133, 895S-920S.
17. McManus, K., Antinoro, L. & Sacks, F. (2001) A randomized controlled trial of a moderate-fat, low-energy diet compared with a low fat, low-energy diet for weight loss in overweight adults. Int. J. Obes. 25, 1503-1511.
18. Melin, I. & Rössner, S. (2003) Practical clinical behavioral treatment of obesity. Patient. Educ. Counc. 49, 75-83.
19. Mifflin, M.D., St Jeor, S.T., Hill, L.A., Scott, B.J., Daugherty, S.A. & Koh, Y.O. (1990) A new predictive equation for resting energy expenditure in healthy individuals. Am. J. Clin. Nutr. 51, 241-247.
20. Norwegian Medicine Agency (2005) Preparatomtale for Xenical (Summary of Product Characteristics for Xenical) for Xenical. Oslo: Legemiddelverket.
21. Pi-Sunyer, F.X., Aronne, L.J., Heshmati, H.M., Devin, J. & Rosenstock, J., for the R.I.O.-North American Study Group. (2006) Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients. JAMA 295, 761-775.
22. Richelsen, B., Tonstad, S., Rössner, S., Toubro, S., Niskanen, L., Madsbad, S., Mustajoki, P. & Rissanen, A. (2007) Effect of orlistat on weight regain and on cardiovascular risk factors following a very-low-calorie diet in abdominally obese patients. A three-year-randomised placebo controlled study. Diabet. Care 30, 27-32.
23. Rimestad, A.H., Blaker, B., Færden, K., Flåten, A.-M., Lund-Larsen, K., Nordbotten, K. & Trygg, K. (1995) Den Store Matvaretabellen (The Norwegian Food Composition Table). Oslo: Universitetsforlaget.
24. Rucker, D., Padwal, R., Li, S.K., Curioni, C. & Lau, D.C.W. (2007) Long-term pharmacotherapy for obesity and overweight: Updated meta analysis. BMJ 335, 1194-1199.
25. Schoeller, D.A. & Buchholz, A.C. (2005) Energetics of obesity and weight control. Does diet composition matter? J. Am. Diet. Assoc. 105, 24S-28S.
26. Speakman, J.R. (2004) Obesity: The integrated roles of environment and genetics. J. Nutr. 134, 2090S-2105S.
27. Subar, A.F., Kipnis, V., Troiano, R.P., Midthune, D., Schoeller, D.A., Bingham, S., Sharbaug, C.O., Trabulsi, J., Runswick, S., Ballard-Barbash, R., Sunshine, J. & Schatzkin, A. (2003) Using intake biomarkers to evaluate the extent of dietary misreporting in a large sample of adults: The OPEN study. Am. J. Epidemiol. 158, 1-13.
28. Svendsen, M. & Tonstad, S. (2006) Accuracy of food intake reporting in obese subjects with metabolic risk factors. Br. J. Nutr. 95, 640-649.
29. Tooze, J.A., Schoeller, D.A., Subar, A.F., Kipnis, V., Schatzkin, A. & Troiano, R. (2007) Total daily energy expenditure among middle-ages men and women: The OPEN Study. Am. J. Clin. Nutr. 86, 382-387.
30. Ullrich, A., Erdmann, J., Margraf, J. & Schusdziarra, V. (2003) Impact of carbohydrate and fat intake on weight-reducing efficacy of orlistat. Allment. Pharmacol. Ther. 17, 1007-1013.
31. Wing, R.R. & Phelan, S. (2005) Long-term weight loss maintenance. Am. J. Clin. Nutr. 82, 222S-225S.